Last updated: March 25, 2024
Sponsor: Rutgers, The State University of New Jersey
Overall Status: Active - Recruiting
Phase
2
Condition
Allergy
Allergies & Asthma
Allergy (Pediatric)
Treatment
Behavioral Exposure For Introceptive Tolerance
Health Education Control
Clinical Study ID
NCT05398276
2021000886
R01AG070136
Ages > 40 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- ≥ 40 years of age
- Elevated exercise anxiety (score of ≥ 30 on ESQ-18)
- Low active (< 90 min self-reported moderate-to-vigorous intensity physicalactivity/day in past three months)
- Medically approved cardiac rehabilitation
- English proficiency
Exclusion
Exclusion Criteria:
- Evidence of cognitive impairment (≤ 23 on Montreal Cognitive Assessment; MoCA)
- Severe disabling chronic medical and/or psychiatric comorbidities determined on acase-by-case basis that prevents safe or adequate participation
- Expectation that patient will not live through study periods
Study Design
Total Participants: 146
Treatment Group(s): 2
Primary Treatment: Behavioral Exposure For Introceptive Tolerance
Phase: 2
Study Start date:
May 03, 2022
Estimated Completion Date:
July 31, 2026
Study Description
Connect with a study center
RWJ Cardiac Rehab at East Brunswick
East Brunswick, New Jersey 08816
United StatesActive - Recruiting
Rutgers Emotion, Health and Behavior Laboratory Department of Psychology
New Brunswick, New Jersey 08901
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.